<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lebas, A</style></author><author><style face="normal" font="default" size="100%">Guyant-Maréchal, L</style></author><author><style face="normal" font="default" size="100%">Hannequin, D</style></author><author><style face="normal" font="default" size="100%">Riant, F</style></author><author><style face="normal" font="default" size="100%">Tournier-Lasserve, E</style></author><author><style face="normal" font="default" size="100%">Parain, D</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation.</style></title><secondary-title><style face="normal" font="default" size="100%">Cephalalgia</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Cephalalgia</style></alt-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008 Jul</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">28</style></volume><pages><style face="normal" font="default" size="100%">774-7</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">We studied four members of a family suffering from typical attacks of familial hemiplegic migraine (FHM) caused by a new mutation, R548C, of ATP1A2 gene in exon 12. One individual had also childhood absence epilepsy and generalized tonic-clonic seizures (GTCS). GTCS were followed by a severe attack of hemiplegic migraine at four times. Sodium valproate enabled control of both the epileptic seizures and the most severe FHM attacks. This association of FHM and epileptic seizures and their control with the same treatment suggest similar pathophysiological mechanisms.</style></abstract><issue><style face="normal" font="default" size="100%">7</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/18498390?dopt=Abstract</style></custom1></record></records></xml>